布地奈德缓释胶囊全新购买方式一览

Introduction: Budesonide sustained-release capsules, as a corticosteroid drug that has shown excellent efficacy in specific countries and regions, have not yet been officially launched in China, but patients can still obtain this treatment option through a variety of formal channels. This article will briefly introduce several new purchase methods and discuss in depth the indications of budesonide extended-release capsules to help patients fully understand this drug.

Overview of new purchasing methods

1. Cooperation with transnational medical institutions: Many international medical institutions have established close cooperative relationships with domestic countries to provide patients with cross-border medical services. Patients can consult and obtain purchase information of budesonide extended-release capsules through these institutions. These institutions usually have a complete supply chain and a team of professional medical consultants to ensure the formal source of drugs and medication guidance.

2. Participate in international clinical trials: For drugs that have not yet been marketed in China, participating in international clinical trials is a cutting-edge and possible way to obtain treatment opportunities. Patients can learn about clinical trial information through hospitals, research institutions or related websites, and apply to participate according to their own conditions. Not only will this provide free treatment, but it will also contribute to drug research and development.

3. Overseas direct mail service: With the rise of cross-border e-commerce, some formal pharmacies or medical supplies platforms have begun to provide overseas direct mail services. Patients can search for budesonide extended-release capsules on these platforms and complete the purchase process according to the platform guidelines.

It is indicated in patients 8 years of age and older for the treatment of mild to moderately active Crohn's disease, particularly if it involves the ileum and/or ascending colon. By inhibiting the inflammatory response, Entocir can effectively relieve patients' symptoms such as abdominal pain and diarrhea and improve their quality of life.

2. Maintenance treatment of Crohn's disease: In adult patients, Entocir is also used to maintain clinical remission of mild to moderate Crohn's disease. It can stabilize the condition, reduce the number of relapses, and help patients maintain long-term health. Especially for Crohn's disease in the ileocecal region, Entocir's therapeutic effect is particularly significant.

3. Exploration of other potential indications: Although the indications of Entocir mentioned at the beginning of this article mainly focus on Crohn's disease, corticosteroids such as budesonide have broad application prospects in the medical field. For example, budesonide has also shown certain efficacy in the treatment of autoimmune diseases such as ulcerative colitis, autoimmune hepatitis, and IgA nephritis.